MiR-21 is overexpressed in response to high glucose and protects endothelial cells from apoptosis

Exp Clin Endocrinol Diabetes. 2013 Jul;121(7):425-30. doi: 10.1055/s-0033-1345169. Epub 2013 Jun 14.

Abstract

Diabetes was an increasing public health problem nowadays. Accumulating evidences had shed a light on the involvement of endothelial cell dysfunction in the pathogenesis of diabetes-associated vascular diseases. MiR-21, a multiple-functional miRNA, was evidenced to be involved in endothelial dysfunction, however, the underlying molecular mechanisms were still unknown. In current study, we investigated the intrinsic link between miR-21 and high glucose-induced endothelial dysfunction. We demonstrated that expression of miR-21 was elevated in circulating endothelial progenitor cells from diabetes patients. Further, inhibition of miR-21 markedly enhanced high glucose-induced endothelial cytotoxicity. Furthermore, proteomic profiling was applied to analyze the downstream effectors involved in miR-21-meidated protection of endothelial cells. A total of 31 proteins were positively identified, including Annexin A2, S100A4, SOD2, Thioredoxin and DAXX. Altered expression of these proteins was validated by immunoblot. Finally, mechanistic study showed that miR-21 protected endothelial cell against high glucose-induced endothelial cytotoxicity probably by inhibiting the expression of DAXX. Our findings were considered as a significant step toward a better understanding of diabetes-associated vascular diseases.

Publication types

  • Clinical Trial
  • Multicenter Study

MeSH terms

  • Adaptor Proteins, Signal Transducing / biosynthesis
  • Aged
  • Aged, 80 and over
  • Annexin A2 / biosynthesis
  • Apoptosis / drug effects*
  • Cells, Cultured
  • Co-Repressor Proteins
  • Diabetic Angiopathies / metabolism*
  • Diabetic Angiopathies / pathology
  • Endothelial Cells / metabolism*
  • Endothelial Cells / pathology
  • Endothelium, Vascular / metabolism*
  • Endothelium, Vascular / pathology
  • Female
  • Glucose / pharmacology*
  • Humans
  • Male
  • MicroRNAs / biosynthesis*
  • Middle Aged
  • Molecular Chaperones
  • Nuclear Proteins / biosynthesis
  • S100 Calcium-Binding Protein A4
  • S100 Proteins / biosynthesis
  • Stem Cells / metabolism*
  • Stem Cells / pathology
  • Superoxide Dismutase / biosynthesis
  • Sweetening Agents / pharmacology*
  • Thioredoxins / biosynthesis

Substances

  • ANXA2 protein, human
  • Adaptor Proteins, Signal Transducing
  • Annexin A2
  • Co-Repressor Proteins
  • DAXX protein, human
  • MIRN21 microRNA, human
  • MicroRNAs
  • Molecular Chaperones
  • Nuclear Proteins
  • S100 Calcium-Binding Protein A4
  • S100 Proteins
  • Sweetening Agents
  • S100A4 protein, human
  • Thioredoxins
  • Superoxide Dismutase
  • superoxide dismutase 2
  • Glucose